Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome - Forschungsportal der Justus-Liebig-Universität Gießen:

Journalartikel

Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome

Autorenliste: Klemm, Philipp; Mueller-Ladner, Ulf; Tarner, Ingo H.; Lange, Uwe; Hudowenz, Ole

Jahr der Veröffentlichung: 2020

Zeitschrift: Autoimmunity Reviews

Bandnummer: 19

Heftnummer: 8

ISSN: 1568-9972

eISSN: 1873-0183

DOI Link: https://doi.org/10.1016/j.autrev.2020.102594

Verlag: Elsevier

Zitierstile

Harvard-Zitierstil: Klemm, P., Mueller-Ladner, U., Tarner, I., Lange, U. and Hudowenz, O. (2020) Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome, Autoimmunity Reviews, 19(8), Article 102594. https://doi.org/10.1016/j.autrev.2020.102594

APA-Zitierstil: Klemm, P., Mueller-Ladner, U., Tarner, I., Lange, U., & Hudowenz, O. (2020). Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome. Autoimmunity Reviews. 19(8), Article 102594. https://doi.org/10.1016/j.autrev.2020.102594

Nachhaltigkeitsbezüge